Literature DB >> 2981766

Analysis of lymphopoietic stem cells with a monoclonal antibody to the rat transferrin receptor.

W A Jefferies, M R Brandon, A F Williams, S V Hunt.   

Abstract

A mouse monoclonal IgG2a antibody, designated MRC OX-26, is shown to be specific for the rat transferrin receptor, but does not block transferrin binding. The antibody labelled a myeloma, three leukaemia cell lines and normal dividing cells of various types, but also bound to a number of nondividing normal tissues. No labelling of lymphopoietic stem cells could be detected, even though approximately 25% of bone marrow and over 95% of fetal liver cells were clearly labelled.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2981766      PMCID： PMC1453509     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  24 in total

1.  T cell leukaemia in the rat: the pathophysiology.

Authors:  M Dibley; S Dorsch; B Roser
Journal:  Pathology       Date:  1975-07       Impact factor: 5.306

2.  THE EFFECT OF DIFFERING DEMANDS FOR BLOOD CELL PRODUCTION ON DNA SYNTHESIS BY HEMOPOIETIC COLONY-FORMING CELLS OF MICE.

Authors:  A J BECKER; E A MCCULLOCH; L SIMINOVITCH; J E TILL
Journal:  Blood       Date:  1965-09       Impact factor: 22.113

3.  Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes.

Authors:  A F Williams; G Galfrè; C Milstein
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

4.  The binding of anti-immunoglobulin antibodies to rat thymocytes and thoracic duct lymphocytes.

Authors:  J C Jensenius; A F Williams
Journal:  Eur J Immunol       Date:  1974-02       Impact factor: 5.532

5.  Kinetic parameters of bone marrow stem cells using in vivo suicide by tritiated thymidine or by hydroxyurea.

Authors:  F Vassort; M Winterholer; E Frindel; M Tubiana
Journal:  Blood       Date:  1973-06       Impact factor: 22.113

6.  Structural features of the cell surface receptor for transferrin that is recognized by the monoclonal antibody OKT9.

Authors:  C Schneider; R Sutherland; R Newman; M Greaves
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

7.  Differences in the surface proteins of mouse B and T cells.

Authors:  I S Trowbridge; P Ralph; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

8.  Purification of human C3b inactivator by monoclonal-antibody affinity chromatography.

Authors:  L Hsiung; A N Barclay; M R Brandon; E Sim; R R Porter
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

9.  Murine cell surface transferrin receptor: studies with an anti-receptor monoclonal antibody.

Authors:  I S Trowbridge; J Lesley; R Schulte
Journal:  J Cell Physiol       Date:  1982-09       Impact factor: 6.384

10.  Lymphocyte cell surface glycoproteins which bind to soybean and peanut lectins.

Authors:  W R Brown; A F Williams
Journal:  Immunology       Date:  1982-08       Impact factor: 7.397
View more
  34 in total

1.  Giant membrane vesicles as a model to study cellular substrate uptake dissected from metabolism.

Authors:  D P Y Koonen; W A Coumans; Y Arumugam; A Bonen; J F C Glatz; J J F P Luiken
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

2.  Regeneration of autotransplanted splenic tissue at different implantation sites.

Authors:  A Liaunigg; C Kastberger; W Leitner; M E Kurz; E S Bergmann; M Seifriedsberger; D Weinlich; W Pimpl; J Thalhamer
Journal:  Cell Tissue Res       Date:  1992-07       Impact factor: 5.249

3.  An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells.

Authors:  Patrick P Ng; Jay S Dela Cruz; David N Sorour; James M Stinebaugh; Seung-Uon Shin; Daniel S Shin; Sherie L Morrison; Manuel L Penichet
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

4.  Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.

Authors:  P M Friden; L R Walus; G F Musso; M A Taylor; B Malfroy; R M Starzyk
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

5.  Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.

Authors:  Patrick P Ng; Gustavo Helguera; Tracy R Daniels; Simon Z Lomas; Jose A Rodriguez; Gary Schiller; Benjamin Bonavida; Sherie L Morrison; Manuel L Penichet
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

6.  Targeting of skeletal muscle in vitro using biotinylated immunoliposomes.

Authors:  Anita Schnyder; Stefan Krähenbühl; Michael Török; Jürgen Drewe; Jörg Huwyler
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

7.  Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.

Authors:  Y Saito; J Buciak; J Yang; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Long-term repopulation of hematolymphoid cells with only a few hemopoietic stem cells in mice.

Authors:  H Ogata; W G Bradley; M Inaba; N Ogata; S Ikehara; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

9.  Polycefin, a new prototype of a multifunctional nanoconjugate based on poly(beta-L-malic acid) for drug delivery.

Authors:  Bong-Seop Lee; Manabu Fujita; Natalya M Khazenzon; Kolja A Wawrowsky; Sebastian Wachsmann-Hogiu; Daniel L Farkas; Keith L Black; Julia Y Ljubimova; Eggehard Holler
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

10.  The organotin-induced thymus atrophy, characterized by depletion of CD4+ CD8+ thymocytes, is preceded by a reduction of the immature CD4- CD8+ TcR alpha beta-/low CD2high thymoblast subset.

Authors:  R H Pieters; M Bol; B W Lam; W Seinen; A H Penninks
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.